News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Photo taken from Julien Mazière/Twitter
Oct 23, 2023, 15:35

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA study from ESMO23 on X/Twitter:

“Another big hit ESMO 23. Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT. Impressive curves and HR 0.24. Immediate practice-changing trial.”

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Source: Julien Mazières/Twitter.

alectinib ALINA study Benjamin J. Solomon cancer ESMO 2023 Julien Mazières OncoDaily Oncology Yi-Long Wu
Special Coverage
Blog
Apr 22, 2025, 18:41
Nurses Community of Practice and GPON Spotlight Advocacy in Precision Oncology - FT3
Blog
Apr 22, 2025, 18:28
Vidith Phillips: AI x Oncology - Research Highlights Shaping Cancer Care in 2025
Blog
Apr 22, 2025, 18:02
Afreen Shariff: Fatigue is not just a side effect - it’s a serious complex, and often overlooked challenge in cancer care
Blog
Apr 22, 2025, 17:31
Vivek Subbiah: It's moments like these that remind me why I do what I do
Positive
Apr 22, 2025, 17:21
Foundation S marks 20 years of impact through My Child Matters - Childhood Cancer International
Blog
Apr 22, 2025, 17:11
Lisa A. Lacasse: We’re able to elevate the patient voice in the fight against cancer at every level of government
Blog
Apr 22, 2025, 17:05
Paul Ekert presents ZERO program at St. Jude Symposium - Children's Cancer Institute
Blog
Apr 22, 2025, 16:58
Wafik S. El-Deiry: Best Practices for Sponsored Research event
Opinion
Apr 22, 2025, 16:42
Nathan Pennell: The Medical community needs to oppose the Department of Justice's threats to journal independence
Blog
Apr 22, 2025, 16:28
Ruben Mesa: Celebrating the extraordinary 27 year tenure of Bayard Powell as the Chief of Hematology and Medical Oncology
Career
Apr 22, 2025, 16:21
Five MD Anderson researchers were honored with 2025 AACR Scientific Achievement Awards
Blog
Apr 22, 2025, 15:38
Nicholas DeVito Highlights Enrollment for BBOpCo Immunotherapy Trial